Peptora
← All peptides

Humanin

★ 65

Humanin (HN, mitochondrial-derived peptide)

Mitochondrial peptide — neuroprotective + longevity

Longevity
Half-life
~30 minutes (SubQ)
Route
SubQ
Cycle
8-12 week cycles,
Status
Strong preclinical (rodent

About

A 24-amino-acid mitochondrial-derived peptide. Sister molecule to MOTS-c. Strong preclinical data for Alzheimer protection, ischemia recovery, and cellular longevity.

Mechanism

Binds the IGFBP-3 / FPR2L receptor complex; activates JAK/STAT3 survival signaling, inhibits Bax-mediated apoptosis, and reduces ER stress.

Dosage

beginner

Amount
5 mg
Frequency
1x per day
Route
Subcutaneous (SubQ)
Duration
4-8 weeks

standard

Amount
5-10 mg
Frequency
1x per day
Route
SubQ
Duration
8-12 weeks

advanced

Amount
10-15 mg
Frequency
1x per day
Route
SubQ
Duration
12 weeks with a 4-week break
Timing

Morning preferred for cognitive effects; any time is fine.

Cycle structure

8-12 week cycles, 4 weeks off.

Reconstitution & Storage

10 mg + 2 mL → 5 mg/mL

Stable peptide. Standard reconstitution protocol.

Lyophilized: refrigerated. Reconstituted: 2-8°C, 28 days.

Benefits

  • • Neuroprotection (Alzheimer models)
  • • Improved insulin sensitivity
  • • Reduced cellular apoptosis
  • • Cardioprotective effects
  • • Mitochondrial biogenesis

Side effects

  • • Generally very well tolerated
  • • Rare: mild fatigue at start
  • • No serious side effects reported in animal studies

Contraindications

  • • Pregnancy (no research)
  • • Active cancer (caution — survival signaling could theoretically protect tumor cells)

Gender notes

Men

Same dose. Popular for cognitive longevity stacks.

Women

Same dose. Endogenous humanin levels decline with menopause — supplementation may have outsized benefit.

Research

Stacks well with

Track Humanin doses in the app

Built-in reconstitution calculator, dose log, and reminders. Free on Android.

Get on Google Play

Educational use only. Not medical advice. Many peptides shown are not FDA-approved and remain research compounds. Always consult a qualified healthcare provider.